Soroush Nedaie, Alex Chan
1. This randomized clinical trial demonstrated that compared with the standard of care, voice-based conversational artificial intelligence ( VBAI) improved time to optimal insulin dosing, insulin adherence, glycemic control, and diabetes-related distress among adults with type 2 diabetes.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Type 2 diabetes affects 33 million US adults, with nearly a quarter having poor glycemic control with a hemoglobin A1c (HbA1c) level above 8%. In these individuals, insulin therapy is essential but requires frequent titrations to achieve the optimal dose...
February 5, 2024: 2 Minute Medicine